{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:02:49Z","timestamp":1788433369063,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011015","name":"International Society of Travel Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.tmaid.2021.102090","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T03:08:56Z","timestamp":1622516936000},"page":"102090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Risk factors for and management of metronidazole-refractory giardiasis in international travellers: A retrospective analysis"],"prefix":"10.1016","volume":"43","author":[{"given":"Tanja E.","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2315-8954","authenticated-orcid":false,"given":"Benno","family":"Kreuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylyn M.","family":"Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert","family":"Tannich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tmaid.2021.102090_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4269\/ajtmh.15-0731","article-title":"Spectrum of imported infectious diseases: a comparative prevalence study of 16,817 German travelers and 977 immigrants from the tropics and subtropics","volume":"94","author":"Herbinger","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.tmaid.2021.102090_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinf.2009.05.008","article-title":"A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellers","volume":"59","author":"Swaminathan","year":"2009","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.tmaid.2021.102090_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa051331","article-title":"Spectrum of disease and relation to place of exposure among ill returned travelers","volume":"354","author":"Freedman","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.tmaid.2021.102090_bib4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/QCO.0000000000000293","article-title":"Giardia: a pathogen or commensal for children in high-prevalence settings?","volume":"29","author":"Bartelt","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"10.1016\/j.tmaid.2021.102090_bib5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4269\/ajtmh.2005.72.825","article-title":"Imported giardiasis: impact of international travel, immigration, and adoption","volume":"72","author":"Ekdahl","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1708-8305.2011.00589.x","article-title":"Spectrum of imported infectious diseases among children and adolescents returning from the tropics and subtropics","volume":"19","author":"Herbinger","year":"2012","journal-title":"J Trav Med"},{"issue":"2","key":"10.1016\/j.tmaid.2021.102090_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2310\/7060.2000.00024","article-title":"Epidemiology of giardiasis in German travelers","volume":"7","author":"Jelinek","year":"2000","journal-title":"J Trav Med"},{"issue":"5","key":"10.1016\/j.tmaid.2021.102090_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taw050","article-title":"Incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers","volume":"23","author":"Takaoka","year":"2016","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2021.102090_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2458-10-41","article-title":"Characteristics and risk factors for symptomatic Giardia lamblia infections in Germany","volume":"10","author":"Espelage","year":"2010","journal-title":"BMC Publ Health"},{"issue":"1","key":"10.1016\/j.tmaid.2021.102090_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1473-3099(14)71000-X","article-title":"Travel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation","volume":"15","author":"Schlagenhauf","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"10.1016\/j.tmaid.2021.102090_bib11","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra1207777","article-title":"Enteropathogens and chronic illness in returning travelers","volume":"368","author":"Ross","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.14.3.447-475.2001","article-title":"Biology of giardia lamblia","volume":"14","author":"Adam","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tmaid.2021.102090_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.meegid.2017.12.001","article-title":"Host specificity in the Giardia duodenalis species complex","volume":"66","author":"Caccio","year":"2018","journal-title":"Infect Genet Evol"},{"issue":"13","key":"10.1016\/j.tmaid.2021.102090_bib14","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.ijpara.2008.04.008","article-title":"Multilocus genotyping of Giardia duodenalis reveals striking differences between assemblages A and B","volume":"38","author":"Caccio","year":"2008","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.tmaid.2021.102090_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1471-2334-9-206","article-title":"Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after","volume":"9","author":"Morch","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exppara.2010.06.014","article-title":"Giardia duodenalis: the double-edged sword of immune responses in giardiasis","volume":"126","author":"Solaymani-Mohammadi","year":"2010","journal-title":"Exp Parasitol"},{"issue":"9","key":"10.1016\/j.tmaid.2021.102090_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ijpara.2011.05.002","article-title":"Host parasite interactions and pathophysiology in Giardia infections","volume":"41","author":"Cotton","year":"2011","journal-title":"Int J Parasitol"},{"issue":"9306","key":"10.1016\/j.tmaid.2021.102090_bib18","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(02)07744-9","article-title":"Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study","volume":"359","author":"Berkman","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.tmaid.2021.102090_bib19","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1017\/S0950268818001504","article-title":"Giardiasis: a diagnosis that should be considered regardless of the setting","volume":"146","author":"Escobedo","year":"2018","journal-title":"Epidemiol Infect"},{"issue":"11","key":"10.1016\/j.tmaid.2021.102090_bib20","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.pt.2017.08.001","article-title":"The intersection of immune responses, microbiota, and pathogenesis in giardiasis","volume":"33","author":"Fink","year":"2017","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.tmaid.2021.102090_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40794-016-0030-0","article-title":"Giardia lamblia infection increases risk of chronic gastrointestinal disorders","volume":"2","author":"Dormond","year":"2016","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/j.tmaid.2021.102090_bib22","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2147\/IDR.S141468","article-title":"Treatment-refractory giardiasis: challenges and solutions","volume":"11","author":"Lalle","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"5","key":"10.1016\/j.tmaid.2021.102090_bib23","first-page":"418","article-title":"[S2k-guideline gastrointestinal infectious diseases and Whipple's disease]","volume":"53","author":"Hagel","year":"2015","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.tmaid.2021.102090_bib24","first-page":"CD007787","article-title":"Drugs for treating giardiasis","volume":"12","author":"Granados","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.tmaid.2021.102090_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/187152610791591610","article-title":"Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives","volume":"10","author":"Lalle","year":"2010","journal-title":"Infect Disord - Drug Targets"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s40475-015-0051-1","article-title":"Drug resistance in the microaerophilic parasite","volume":"2","author":"Leitsch","year":"2015","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.tmaid.2021.102090_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.actatropica.2016.06.026","article-title":"Combination therapy in the management of giardiasis: what laboratory and clinical studies tell us, so far","volume":"162","author":"Escobedo","year":"2016","journal-title":"Acta Trop"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002733","article-title":"Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials","volume":"8","author":"Pasupuleti","year":"2014","journal-title":"PLoS Neglected Trop Dis"},{"issue":"12","key":"10.1016\/j.tmaid.2021.102090_bib29","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1517\/14656566.8.12.1885","article-title":"Giardiasis: a pharmacotherapy review","volume":"8","author":"Escobedo","year":"2007","journal-title":"Expet Opin Pharmacother"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/jac\/dkx430","article-title":"Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials","volume":"73","author":"Ordonez-Mena","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.tmaid.2021.102090_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmi.2015.04.019","article-title":"Increased incidence of nitroimidazole-refractory giardiasis at the hospital for tropical diseases, London: 2008-2013","volume":"21","author":"Nabarro","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.tmaid.2021.102090_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1086\/320886","article-title":"Treatment of patients with refractory giardiasis","volume":"33","author":"Nash","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2021.102090_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4269\/ajtmh.2010.09-0742","article-title":"Short course combination therapy for giardiasis after nitroimidazole failure","volume":"83","author":"Lopez-Velez","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.tmaid.2021.102090_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cmi.2017.05.028","article-title":"Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions","volume":"24","author":"Carter","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.tmaid.2021.102090_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/QCO.0000000000000668","article-title":"Giardiasis treatment: an update with a focus on refractory disease","volume":"33","author":"M\u00f8rch","year":"2020","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.tmaid.2021.102090_bib36","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jinf.2008.01.013","article-title":"Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway","volume":"56","author":"Morch","year":"2008","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.tmaid.2021.102090_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3201\/eid2201.151272","article-title":"Increased risk for ESBL-producing bacteria from Co-administration of loperamide and antimicrobial drugs for travelers' diarrhea","volume":"22","author":"Kantele","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmaid.2021.102090_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tmaid.2017.01.003","article-title":"Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - data of a prospective traveller study","volume":"16","author":"Kantele","year":"2017","journal-title":"Trav Med Infect Dis"},{"issue":"suppl_1","key":"10.1016\/j.tmaid.2021.102090_bib39","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/jtm\/taw101","article-title":"Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level","volume":"24","author":"Woerther","year":"2017","journal-title":"J Trav Med"},{"issue":"6","key":"10.1016\/j.tmaid.2021.102090_bib40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ng.3281","article-title":"Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events","volume":"47","author":"Wong","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.tmaid.2021.102090_bib41","first-page":"101521","article-title":"Intestinal colonization with extended-spectrum beta-lactamase producing Enterobacterales (ESBL-PE) during long distance travel: a cohort study in a German travel clinic (2016-2017)","author":"Meurs","year":"2019","journal-title":"Trav Med Infect Dis"},{"issue":"9","key":"10.1016\/j.tmaid.2021.102090_bib42","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/jac\/dkt167","article-title":"Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors","volume":"68","author":"Ostholm-Balkhed","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib43","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JCM.43.3.1205-1209.2005","article-title":"Analysis of Salmonella enterica serotype Typhi pulsed-field gel electrophoresis patterns associated with international travel","volume":"43","author":"Kubota","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.tmaid.2021.102090_bib44","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1128\/JCM.00593-12","article-title":"Molecular typing and resistance analysis of travel-associated Salmonella enterica serotype Typhi","volume":"50","author":"Tatavarthy","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tmaid.2021.102090_bib45","first-page":"281","article-title":"Rationalizing antibiotic use to limit antibiotic resistance in India","volume":"134","author":"Ganguly","year":"2011","journal-title":"Indian J Med Res"},{"issue":"4","key":"10.1016\/j.tmaid.2021.102090_bib46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0277-9536(02)00422-7","article-title":"Improving antibiotic use in low-income countries: an overview of evidence on determinants","volume":"57","author":"Radyowijati","year":"2003","journal-title":"Soc Sci Med"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2009.11.005","article-title":"Impact of poor-quality medicines in the 'developing' world","volume":"31","author":"Newton","year":"2010","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"10.1016\/j.tmaid.2021.102090_bib48","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3201\/eid2010.140073","article-title":"Treatment of giardiasis after nonresponse to nitroimidazole","volume":"20","author":"Meltzer","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2021.102090_bib49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tmaid.2012.10.004","article-title":"Refractory giardiasis in Spanish travellers","volume":"11","author":"Munoz Gutierrez","year":"2013","journal-title":"Trav Med Infect Dis"},{"issue":"6","key":"10.1016\/j.tmaid.2021.102090_bib50","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/infdis\/jix066","article-title":"The use of quinacrine in nitroimidazole-resistant giardia duodenalis: an old drug for an emerging problem","volume":"215","author":"Requena-Mendez","year":"2017","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2021.102090_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.14.1.114-128.2001","article-title":"Treatment of giardiasis","volume":"14","author":"Gardner","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1179\/136485908X267894","article-title":"The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide","volume":"102","author":"Escobedo","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"issue":"9","key":"10.1016\/j.tmaid.2021.102090_bib53","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1046\/j.1365-2036.2001.01066.x","article-title":"Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru","volume":"15","author":"Ortiz","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib54","first-page":"122","article-title":"[Effectiveness and safety of mebendazole compared to nitazoxanide in the treatment of Giardia lamblia in children]","volume":"64","author":"Rodriguez-Garcia","year":"1999","journal-title":"Rev Gastroenterol M\u00e9xico"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/322038","article-title":"Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide","volume":"184","author":"Rossignol","year":"2001","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.tmaid.2021.102090_bib56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/hup.427","article-title":"Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis","volume":"17","author":"Genel","year":"2002","journal-title":"Hum Psychopharmacol"},{"issue":"39","key":"10.1016\/j.tmaid.2021.102090_bib57","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.3748\/wjg.v12.i39.6366","article-title":"Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children","volume":"12","author":"Canete","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.tmaid.2021.102090_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab513","article-title":"Efficacy and tolerability of quinacrine monotherapy and albendazole plus chloroquine combination therapy in nitroimidazole-refractory giardiasis: a TropNet study","author":"Neumayr","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.tmaid.2021.102090_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004261","article-title":"Time-dependent transcriptional changes in Axenic giardia duodenalis trophozoites","volume":"9","author":"Ansell","year":"2015","journal-title":"PLoS Neglected Trop Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2021.102090_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s40475-015-0051-1","article-title":"Drug resistance in the microaerophilic parasite giardia lamblia","volume":"2","author":"Leitsch","year":"2015","journal-title":"Curr Trop Med Rep"},{"issue":"5","key":"10.1016\/j.tmaid.2021.102090_bib61","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/aem.58.5.1530-1533.1992","article-title":"Comparison of an in vitro method and an in vivo method of Giardia excystation","volume":"58","author":"Isaac-Renton","year":"1992","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.tmaid.2021.102090_bib62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12936-018-2586-9","article-title":"Area of exposure and treatment challenges of malaria in Eritrean migrants: a GeoSentinel analysis","volume":"17","author":"Schlagenhauf","year":"2018","journal-title":"Malar J"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893921001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893921001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:07:31Z","timestamp":1761487651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893921001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":62,"alternative-id":["S1477893921001319"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2021.102090","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for and management of metronidazole-refractory giardiasis in international travellers: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2021.102090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102090"}}